LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that its Venezuelan operating affiliate, LataMed AI VE, has accepted an invitation from the Faculty of Medicine at Universidad Central de Venezuela (UCV) to participate in educational sessions on HealthTech innovation, digital healthcare technologies, and artificial intelligence applications in healthcare environments.
The sessions are expected to provide students and faculty with exposure to emerging healthcare technologies, telehealth infrastructure concepts, healthcare coordination tools, analytics, emergency response technologies, and evolving AI applications within healthcare delivery systems. Management believes this academic engagement represents a strategic opportunity to increase awareness of digital healthcare innovation among future healthcare professionals and to foster dialogue regarding technology-enabled healthcare solutions throughout Latin America.
Participation in the UCV program is expected to provide an opportunity for the Company to engage with future physicians, healthcare leaders, researchers, and educators regarding developments in digital health infrastructure and emerging healthcare technologies. The educational sessions are intended solely for academic and informational purposes and do not constitute endorsements, commercial arrangements, recommendations, or evaluations of any specific products, services, or technologies.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “We are honored to engage with students and faculty members at one of Venezuela’s most respected academic institutions. We believe meaningful collaboration between healthcare professionals, educators, and technology innovators is increasingly important as healthcare systems evaluate digital solutions designed to improve access, coordination, efficiency, and patient outcomes. Educational initiatives such as this support knowledge sharing and encourage discussion regarding the future role of digital healthcare technologies across Latin America.”
For additional information, visit https://latamed.ai or review the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
